沪深北交易所优化再融资政策支持优质及科创企业融资主板引入"轻资产、高研发投入"认定标准 商务部：我国超大规模市场基础牢全链条扩大汽车消费大有可为 市场监管总局发布系列制度文件加强重点液态食品道路散装运输管理 2月9日，沪深北交易所宣布优化再融资一揽子措施。在进一步支持优质上市公司创新发展方面，沪深北交易所明确，对经营治理与信息披露规范，具有代表 性与市场认可度的优质上市公司，优化再融资审核，进一步提高再融资效率。同时，为更好适应科创企业再融资需求，沪深交易所已修订上市公司"轻资 产、高研发投入"规则，明确主板企业认定标准。沪深北交易所存在破发情形的上市公司，可以通过定增、发行可转债等方式合理融资，募集资金需投向主 营业务。此外，沪深北交易所还明确提升再融资灵活性、便利度，加强再融资全过程监管。（新华社） 俄罗斯外交部长拉夫罗夫9日表示，俄罗斯绝不允许在乌克兰境内部署任何威胁俄安全利益的武器。（新华社） 日本东京电力公司9日说，为调查故障原因而暂时关闭的日本柏崎刈羽核电站6号机组9日再次启动。（新华社） 日本厚生劳动省9日公布的初步统计结果显示，由于通货膨胀持续，扣除物价上涨因素后，2025年日本人均实际工资比 ...

Core Viewpoint - Several companies are engaging in significant transactions, including acquisitions, share repurchases, and performance disclosures, indicating active market movements and strategic adjustments in response to industry conditions [1][2][4][5][6][7][8][9]. Group 1: Acquisitions and Mergers - Efort plans to acquire 100% of Shengpu shares through a combination of share issuance and cash payments, with the transaction expected to enhance business scale and profitability [2]. - Hainan Mining intends to purchase 69.90% of Fengrui Fluorine Industry through share issuance and cash payments, aiming to expand its strategic resource portfolio [9]. - China National Aviation has received approval for a private placement of A-shares, facilitating its capital raising efforts [10]. Group 2: Share Repurchases - Huatai Medical plans to repurchase shares at a price not exceeding 315 CNY per share, with a total repurchase amount between 150 million and 200 million CNY [4]. - Electric Connection Technology aims to repurchase shares for employee stock ownership plans, with a budget of 100 million to 200 million CNY [4]. - Gaweida intends to repurchase shares with a total budget of 30 million to 35 million CNY, aimed at reducing registered capital [4]. Group 3: Performance Reports - Dongwei Technology reported a 2025 net profit increase of 86.81% year-on-year, driven by growth in PCB equipment orders [6]. - Weimais reported a 39.22% increase in net profit for 2025, attributed to the growth in the domestic electric vehicle market [6]. - Qianjin Pharmaceutical's net profit grew by 24.74% in 2025, supported by stable revenue from core industrial enterprises [7]. Group 4: Regulatory and Compliance Issues - Cuihua Jewelry is under investigation by the China Securities Regulatory Commission for suspected information disclosure violations [5]. - ST Energy is facing a potential change in control due to share pledges, leading to a trading suspension [12]. Group 5: Investment Projects - Yuanjie Technology plans to invest approximately 12.51 billion CNY in a semiconductor chip and device R&D production base [19]. - Mengguoli intends to invest 9.29 billion CNY in a lithium-ion battery cathode material project, with the first phase already approved [12]. - Optoelectronics plans to issue convertible bonds to raise up to 13.8 billion CNY for expansion projects [17].

Group 1 - Jinwei Co., Ltd. plans to acquire 100% equity of Fusheng Mining for 210 million yuan, which will become a wholly-owned subsidiary and included in the consolidated financial statements [2] - Mengguli intends to invest 929 million yuan to build a project with an annual production capacity of 30,000 tons of lithium-ion battery cathode materials, expected to produce 5,000 tons of high-voltage cobalt acid lithium, 10,000 tons of NCA materials, and 15,000 tons of ultra-high nickel ternary materials [2] - Xiamen Tungsten plans to acquire 39% equity of Jiujiang Dadi Mining, which will help increase mineral resource reserves and improve raw material self-sufficiency [3] Group 2 - Andavil's subsidiary received EASA certification for its aviation kitchen plug-in products, marking compliance with European aviation safety standards [2] - CIMC Vehicles disclosed that the US ITC made a preliminary ruling on anti-subsidy and anti-dumping investigations regarding Van-Type Trailers, indicating potential damage to the US domestic industry [4] - Source Technology plans to invest approximately 1.251 billion yuan to build a second phase project for the R&D and production of optoelectronic communication semiconductor chips and devices [9] Group 3 - Zhongmin Energy intends to acquire 51% equity of Mintou Pumped Storage for 864 million yuan, with the transaction price based on asset evaluation [10] - Ningbo Yunsheng plans to publicly issue H-shares and apply for listing on the Hong Kong Stock Exchange [11] - Wenkai Co., Ltd. won a bid for a landscape project worth 50.8162 million yuan [12] Group 4 - China Merchants Shekou achieved a signed sales amount of 7.674 billion yuan in January 2026 [16] - AVIC Optoelectronics reported a net profit of 2.124 billion yuan for 2025, a year-on-year decrease of 36.69% [17] - Tiankang Bio reported a sales revenue of 392 million yuan from pig sales in January 2026, with a month-on-month increase of 6.23% [18] Group 5 - Poly Developments reported a signed amount of 15.617 billion yuan in January 2026, a year-on-year decrease of 13.31% [19] - Chengtou Holdings reported a net profit of 290 million yuan for 2025, a year-on-year increase of 19.67% [20] - Qianjin Pharmaceutical reported a net profit of 288 million yuan for 2025, a year-on-year increase of 24.74% [21]

Group 1 - The company, XianDao Intelligent (300450), has announced the final price for its H-share issuance at HKD 45.80 per share [1] - The company is expected to be listed and commence trading on the Hong Kong Stock Exchange main board on February 11, 2026 [1]

Core Viewpoint - The company has set the final price for its H-share issuance at HKD 45.80 per share, with plans to list on the Hong Kong Stock Exchange on February 11, 2026 [1] Group 1 - The final price for the H-share issuance is confirmed at HKD 45.80 [1] - The listing on the Hong Kong Stock Exchange is scheduled for February 11, 2026 [1]

Group 1 - XianDao Intelligent has set the final price for its H-share public offering at HKD 45.8 per share, with expected listing on February 11, 2026 [1] - Jida Communication is a candidate for a project with China Mobile, with an estimated service fee of approximately CNY 51.04 million [2] - Bowei Alloy's controlling shareholder plans to increase holdings by CNY 100 million to 150 million from February 10 to August 9, 2026 [3] Group 2 - Xiamen Airport reported 16,368 aircraft takeoffs and landings in January 2026, a year-on-year decrease of 4.82%, with passenger throughput of 2.38 million, down 3.84% [4] - Yitong Century has won a bid for a project worth CNY 107 million, providing comprehensive maintenance services for China Tower [5] - Huayi Brothers' controlling shareholder's 70 million shares are subject to judicial auction, representing 42.89% of his holdings and 2.52% of the company's total shares [6] Group 3 - Lianhuan Pharmaceutical received approval for the sale of Tadalafil tablets (20mg) in Ghana [7] - Aonong Biological reported a pig sales volume of 166,600 in January 2026, a year-on-year increase of 35.36% [8] - Xiantan Co. achieved chicken product sales revenue of CNY 546 million in January 2026, a year-on-year increase of 54.9% [9] Group 4 - Zhengbang Technology reported a January sales revenue of CNY 816 million from pig sales, a year-on-year increase of 19.69% [10] - Qianjin Pharmaceutical's net profit for 2025 grew by 24.74% to CNY 288 million [11] - Xinhua Pharmaceutical received a drug registration certificate for glucosamine sulfate capsules [12] Group 5 - Yuandong Bio completed the first dosing of its EP-0210 monoclonal antibody in a Phase I clinical trial for inflammatory bowel disease [13] - Jiaokong Technology signed a contract for the Sydney Metro West Line signal system subcontracting project worth AUD 93.53 million [14] - Dangsheng Technology signed a strategic cooperation framework agreement with Huineng Technology in solid-state batteries and the new energy industry [15] Group 6 - Jinhui Co. plans to acquire 100% of Fusheng Mining for CNY 210 million [16] - Cangzhou Mingzhu announced Guangzhou Light Industry as its new controlling shareholder after a share transfer [17] - Dingxin Technology's vice president was fined CNY 120,000 for short-term trading [18][19] Group 7 - China Modern Pharmaceutical's subsidiary passed a GMP compliance inspection for its production line [20] - Chaosheng Electronics plans to increase capital by CNY 400 million in its subsidiary to enhance competitiveness [21] - Lonyu Mountain reported a 25.03% year-on-year increase in pig sales revenue in January 2026 [22] Group 8 - Sanbo Brain Science's chairman has been released from investigation, and the company is operating normally [23] - Hainan Mining is planning to acquire control of Luoyang Fengrui Fluorine Industry and will resume trading on February 10, 2026 [24] - Dongwei Technology's net profit for 2025 increased by 86.81% [25] Group 9 - Yuanjie Technology plans to invest CNY 1.251 billion in a semiconductor chip and device R&D production base [26] - Metro Design signed a contract for an energy management project with Guangzhou Metro Group worth CNY 924 million [27] - Zhongmin Energy intends to acquire 51% of Fujian Yongtai Mintou Pumped Storage Co. for CNY 864 million [28] Group 10 - Dianzhi Technology plans to repurchase shares worth CNY 100 million to 200 million [29] - China Baoan was not selected as a restructuring investor for the Singshan Group [30] - Zhiguang Electric's subsidiary signed a CNY 1.004 billion contract for energy storage systems [31] Group 11 - Zhifei Biological received approval for a clinical trial of its herpes zoster vaccine [32] - KQ Bio received a new veterinary drug registration certificate for a vaccine against porcine circovirus type 2 [33] - Huanxu Electronics reported a 4% year-on-year increase in consolidated revenue for January 2026 [34] Group 12 - Xiangjia Co. reported a 10.42% year-on-year increase in live poultry sales revenue in January 2026 [35] - Kemin Foods' subsidiary reported a 68.29% year-on-year increase in pig sales revenue in January 2026 [36] - Liyuan Technology signed a procurement contract worth CNY 54.98 million [37] Group 13 - Jiuqiang Bio received a medical device registration certificate for a fibrin degradation product detection kit [38] - Zhongguancun's subsidiary passed the consistency evaluation for Tramadol Hydrochloride tablets [39] - Rundou Co. received a drug registration certificate for Candesartan Etil [40]

Core Viewpoint - The company, Xian Dao Intelligent (00470.HK), has set the offering price for its H-shares at HKD 45.80 per share, excluding various fees [1] Group 1: Offering Details - The company will issue and allocate an additional 14,042,400 shares, which represents approximately 15.0% of the total shares available for subscription under the global offering [1] - The company expects to announce the level of interest in the international offering, the application level for the Hong Kong public offering, and the allocation results on February 10, 2026 [1] - The global offering is anticipated to become unconditional by February 11, 2026, with H-shares expected to commence trading on the Hong Kong Stock Exchange at 9:00 AM [1] Group 2: Trading Information - H-shares will be traded in board lots of 100 shares [1]

Core Viewpoint - The company, XianDao Intelligent (300450), has set the offering price for its H shares at HKD 45.80 per share as of February 8, 2026, and has exercised the over-allotment option to issue an additional 14.0424 million shares, representing approximately 15.0% of the total shares available for subscription under the global offering [1]. Group 1 - The offering price for the H shares is established at HKD 45.80 [1] - The company will issue and allocate an additional 14.0424 million shares [1] - The additional shares represent about 15.0% of the total shares available for subscription [1]

Group 1 - The company, XianDao Intelligent (00470), has set the offering price for its H shares at HKD 45.80 per share as of February 8, 2026 [1] - The overallotment option has been fully exercised, leading the company to issue and allocate an additional 14.0424 million shares, which represents approximately 15.0% of the total shares available for subscription under the global offering [1]

Core Viewpoint - The company, XianDao Intelligent (300450.SZ), has set the final price for its H-share issuance at HKD 45.80 per share, excluding various transaction fees [1] Group 1: H-share Issuance Details - The H-share issuance is expected to be listed and commence trading on the Hong Kong Stock Exchange on February 11, 2026 [1] - The issuance price does not include a 1.0% brokerage commission, a 0.0027% transaction fee from the Hong Kong Securities and Futures Commission, a 0.00565% transaction fee from the Hong Kong Stock Exchange, and a 0.00015% transaction fee from the Hong Kong Institute of Certified Public Accountants [1]